Fintel reports that on December 11, 2024, Wells Fargo initiated coverage of BioNTech SE - Depositary Receipt () (BRSE:22UA) with a Overweight recommendation.
What is the Fund Sentiment?
There are 428 funds or institutions reporting positions in BioNTech SE - Depositary Receipt (). This is an increase of 32 owner(s) or 8.08% in the last quarter. Average portfolio weight of all funds dedicated to 22UA is 0.36%, an increase of 33.61%. Total shares owned by institutions increased in the last three months by 4.27% to 52,495K shares.
What are Other Shareholders Doing?
Baillie Gifford holds 8,308K shares. In its prior filing, the firm reported owning 8,276K shares , representing an increase of 0.38%. The firm increased its portfolio allocation in 22UA by 42.52% over the last quarter.
Primecap Management holds 4,517K shares. In its prior filing, the firm reported owning 4,790K shares , representing a decrease of 6.04%. The firm increased its portfolio allocation in 22UA by 41.54% over the last quarter.
Flossbach Von Storch holds 4,360K shares. In its prior filing, the firm reported owning 4,379K shares , representing a decrease of 0.46%. The firm increased its portfolio allocation in 22UA by 37.66% over the last quarter.
VHCOX - Vanguard Capital Opportunity Fund Investor Shares holds 2,271K shares. In its prior filing, the firm reported owning 2,372K shares , representing a decrease of 4.47%. The firm increased its portfolio allocation in 22UA by 40.42% over the last quarter.
Temasek Holdings holds 1,807K shares. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
